NPACE Pharmacology Bundle

Total price: $560.00
Select quantity

Details

PROGRAM DESCRIPTION

This is an essential package for all nurse practitioner students and new NPs. This package includes important primary care topics including, barriers to vaccination; management and treatment of anxiety; treatment of c. diff and h. pylori; community-acquired pneumonia; pharmacologic management of dyslipidemia, pain, sleep disorders, headaches, obesity, thyroid disorders, depression, migraines, and liver disease; and management of hypertension and diabetes.


FORMAT OPTIONS

Streaming Online Video:

Instant access! Place your order. Receive a welcome email and you're ready to go. No waiting!

View your videos. Complete your evaluations. Print your certificates. It's that easy!


ACCESS

Internet browser: Google Chrome is required for viewing via a browser. Go to the CE Center and log in using your APEA account username and password. Find your course and click on the title of a lecture to open the player and view each video. The Course Manual may be downloaded or printed from the CE Center.


Access the course content via the APEA app for iOS or via browser. A new APEA app for Android is in development. Therefore, downloading of the course on an Android phone is temporarily unavailable. Android users can access the course via browser (instructions below).


APEA app: Download the app for iOS. Log in with your APEA account username and password. Find your course in the CE Center. Download the audio files. Print or download the Course Manual.



LEARNING OBJECTIVES

Addressing Barriers in Vaccination Uptake and Integration

After taking part in this educational activity, participants should be better able to:

Effectively integrate vaccine education, information and implementation into clinical practice

Confidently administer vaccines in adherence to the recommended guidelines and intervals to advance disease prevention and vaccine uptake

Navigate, initiate and foster patient and caregiver support, informed decision-making, and education

Advance disease prevention opportunities by identifying and addressing factors related to vaccine hesitancy


Pharmacologic Management of Dyslipidemia in Primary Care

After taking part in this educational activity, participants should be better able to:

Analyze newest guideline recommendations for the treatment of dyslipidemia

Compare and contrast pharmacotherapeutic options for the very high-risk patient

Apply treatment guidelines to both average and very high-risk patient


Updates in the Management of Hypertension

After taking part in this educational activity, participants should be better able to:

As a result of this activity, the learner will be able to list non-pharmacological approaches for management of hypertension

As a result of this activity, the learner will be able to recommend appropriate evidenced based pharmacological options to achieve goal blood pressure goals

As a result of this activity, the learner will be able to identify the role of team based hypertension care in maximizing hypertension management goals


Diabetes Management: Managing Insulin and Injectable Therapies

After taking part in this educational activity, participants should be better able to:

Discuss when and how to initiate/titrate basal and prandial/correction boluses

Describe how to safely and effectively manage the use of GLP1-1 agonist injectables alone or in combination with basal insulin.

Specify what blood glucose data (finger-stick or CGM) is most helpful to bettering managing glycemic control.


Migraine Pharmacotherapy, 2023 Update

After taking part in this educational activity, participants should be better able to:

Develop a strategy to diagnose migraine headache and guide to treatment

Recognize mechanism of action and clinical profiles of therapeutic options for acute and preventative treatment

Apply evidence-based research to guide pharmacology selection


An Evidence-Based Approach to Maximizing Benefit & Limiting Antibiotic Risks in Community-Acquired Pneumonia

After taking part in this educational activity, participants should be better able to:

Describe the etiologic trends of pneumonia in the community.

Identify relevant antimicrobial related factors such as mechanism of action, duration of action, side effects, and spectrum of activity influencing the optimal empiric therapy for pneumonia.

Discriminate clinical scenarios requiring initiation of single versus combination antibiotic therapy for pneumonia in the community


Analyzing Existing Evidence to Inform Appropriate Use of Antivirals for Influenza and COVID-19 Infections

After taking part in this educational activity, participants should be better able to:

Identify key features for antivirals used to treat influenza and COVID-19, such as mechanism of action, duration of action, and side effects.

Discuss the evidence for the effectiveness and safety of antivirals used to treat influenza and COVID-19

Develop an approach to the appropriate use of antivirals for influenza and COVID-19 infections in clinical practice.


Gut Bugs: Updates on the Treatment of Clostridium Difficile and H. pylori

After taking part in this educational activity, participants should be better able to:

Discuss the epidemiology, pathogenesis and diagnosis of Clostridium Difficile (C. diff) and Helicobacter Pylori ( H. Pylori)

Understand emerging antimicrobial resistant patterns for both diseases

Review evidence based first line treatment strategies for C. Diff and H. Pylori

Discuss options for management of relapse and salvage therapy when first line treatment fails


Pharmacologic Management of Headaches

After taking part in this educational activity, participants should be better able to:

Differentiate between primary and secondary headaches

State the 4 primary headache types

Discuss preventative and acute pharmacotherapies for each primary headache disorder


Pharmacologic Management of Sleep Disorders in Primary Care

After taking part in this educational activity, participants should be better able to:

Analyze the biopsychosocial pathophysiology of insomnia

Discuss mechanisms of arousal contributing to insomnia

Compare and contrast pharmacologic options for insomnia


Pharmacological Management Options for the Treatment of Obesity

After taking part in this educational activity, participants should be better able to:

Review the current burden of obesity in diabetes

Go through the approved weight reduction medications and secondary weight benefit treatments

Asses the necessary steps to ensure engagement, reduce barriers, and maximize benefit to Prescriber and Person.

Explore CGM as a strategy for weight reduction.


Pharmacology Updates in Liver Disease

After taking part in this educational activity, participants should be better able to:

Understand the pathophysiology and epidemiology of liver cirrhosis

Review common complications associated with decompensated liver cirrhosis and management options

Review medication considerations in cirrhosis and chronic liver disease (CLD)

Discuss current pharmacology in management of other common chronic liver diseases (CLD)


Pharmacotherapy for Thyroid Disorders: Making it Safe, Appropriate, & Effective

After taking part in this educational activity, participants should be better able to:

Relate the effects of thyroid hormone and the H-P-T axis on the presentation & laboratory diagnosis of hyper- and hypothyroid states

Effectively and safely administer thyroid replacement drugs in clinical & subclinical hypothyroid disorders (Including post-partum thyroiditis)

Effectively and safely administer anti-thyroid hormone drugs (ATD) and other intervention medications in clinical & subclinical hyperthyroid disorders(including subacute thyroiditis)


Updates in the Management of Type 2 DM

After taking part in this educational activity, participants should be better able to:

As a result of this activity, the learner will be able to compare the most updated clinical guidelines from the American Diabetes Association to the American Association of Clinical Endocrinology guidelines

As a result of this activity, the learner will be able to recommend appropriate evidenced based pharmacological options to achieve goal A1c in DM2 and DM2 with specific co-morbid conditions

As a result of this activity, the learner will be able to identify the role of DM2 medications in non-diabetic patients


Updates in the Pharmacologic Management of Pain

After taking part in this educational activity, participants should be better able to:

Discuss where medications work in the pain pathway(s)

Explore use of opioid analgesics for pain management

State different non-opioid pharmaceuticals for pain management



TIME TO COMPLETE


Each video is accessible twice within six months of purchase.


CREDITS

NPACE designates this educational activity for a maximum of 25 CNE credit(s), of which 22.95 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.


DISCLAIMER

The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.


DISCLOSURE OF UNLABELED USE

This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.



ACCREDITED PROVIDER

Provider Accreditation Statement

This program is provided by Nurse Practitioner Associates for Continuing Education (NPACE).


Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).


In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.


NPACE, the Provider of awarding contact hours, is responsible for adherence to ANCC criteria.


FACULTY

Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Family Nurse Practitioner and Owner; Wright & Associates Family Healthcare

Wendy received her Doctor of Nursing Practice in 2019 from the University of Alabama, Tuscaloosa. She is a 1992 graduate of the Adult Primary Care Nurse Practitioner program at Simmons College in Boston, Massachusetts and completed a family nurse practitioner post-master’s program in 1995. She is an adult and family nurse practitioner and the owner of two, nurse practitioner owned and operated clinics within New Hampshire named: Wright & Associates Family Healthcare. Her family practices have won numerous awards, including Top Providers in New Hampshire 2018, Top 20 Fastest-Growing Family Business, and Top 20 Women-Owned Business in New Hampshire. In addition, she is the Owner of Partners in Healthcare Education, a medical education company. She is the Past President of NPACE and the Senior lecturer for Fitzgerald Health Education Associates.

She is the recipient of numerous awards and was chosen by the American Association of Nurse Practitioners as the 1999 recipient of the New Hampshire State Excellence Award. In addition, she received the 2009 NH Nurse Practitioner of the Year and the 2014 Top 5 Women in New Hampshire Business Award. In 2005, she was inducted as a Fellow into the American Academy of Nurse Practitioners; in October 2014, a Fellow in the American Academy of Nursing, and in March 2017, a Fellow into the National Academies of Practice.

She is the founder of the NH Chamber of Entrepreneurial Nurse Practitioners, an organization designed to assist nurse practitioners with independent practice issues. In addition to full-time clinical practice, she presents nationally to different audiences and has been a speaker at over 1000 conferences in 47 states. She is the nurse practitioner representative to the State of NH Immunization Advisory Board. She has been a medical media spokesperson for numerous companies and has appeared on radio, television, and in print magazines. Wendy is frequently consulted by malpractice attorneys around the area of clinical practice and has worked on more than 100 malpractice cases involving nurses and nurse practitioners.


Sally K. Miller, PhD, APRN, FAANP, PMHNP-BC, FNP-BC, AGACNP-BC, AGPCNP-BC

Clinical Professor, Drexel University CNHP; Nurse Practitioner, iCarePsychiatry and Sahara Family Practice

Dr. Sally Miller has been practicing as a nurse practitioner for 29years. She is board certified as a family NP, Adult/Geriatric Acute and Primary NP, and Psych/Mental Health NP. Dr. Miller is a clinical professor with Drexel University College of Nursing and Health Professions. She maintains an active clinical practice with iCarePsychiatry. Sally has published over 30 research and clinical articles with emphasis on issues related to adult health and illness as well as obesity. She has been an active conference presenter and author in the NP community since 1996.


Angela Golden, DNP, FNP-C, FAANP

Owner and Provider; NP From Home, LLC

Dr. Angela Golden, is a current fellow and past president of the American Association of Nurse Practitioners. Her tenure as the president of the AANP gives her a unique and overarching perspective of the multifunctional role of the Nurse Practitioner. For the past 26 years, Angie has had her own practice—NP from Home, LLC—where she provides clinical services in a family practice and for the past 7 years a subspecialty obesity practice, NP Obesity Treatment Clinic.

Angie has a great deal of experience in leadership positions and clinical practice. She has authored peer-reviewed articles and book chapters covering a range of health topics including health policy. She has presented nationally and internationally with an emphasis on health policy, leadership, and various clinical topics.


Christine Kessler, MN, ANP, CNS, BC-ADM, CDTC, FAANP

Founder and Clinical Consultant; Metabolic Medicine Associates

Christine is an award-winning NP, national/international speaker, prolific author, and clinical consultant specializing in General Endocrinology, Obesity, Metabolic, and Genomic Medicine. In her more than 4 decades of advanced nursing practice, she’s held diverse roles in academia (Assistant Professor in undergraduate & graduate nursing), research, and clinical practice; the latter as a critical care clinical specialist and ACNP intensivist (20 years) and an endocrine specialist (23 years). During her 16 years as a Senior NP at the Department of Endocrinology & Metabolic Medicine at Walter Reed National Military Medical Center, she established the first weight loss clinic at her military facility, within her Endocrine practice. Since then, Christine founded Metabolic Medicine Associates where she provides general endocrine services (in underserved locations) and weight-loss management, as well as endocrine consultation to healthcare providers nationally. Christine has received numerous top clinical practice and patient satisfaction awards, including the Fort Belvoir Hospital Department of Medicine’s Silver Ace award for being voted the top Medical Provider by her peers, and the rare Coin of Excellence personally awarded to her by the Surgeon General for having the highest patient satisfaction rating of all health care providers in the Army WORLDWIDE. Christine is a Fellow of the American Association of Nurse Practitioners.


Jason Cross, PharmD, BCPS, BCACP

Jason is an Associate Professor of Pharmacy at MCPHS University. He completed his PharmD at the University of Rhode Island, College of Pharmacy in 2001. In 2002, he completed a Pharmacy Residency at UMass Memorial Medical Center. Since 2002, he has been a full time faculty member at MCPHS University focusing on adult in-patient internal medicine, acute heart failure, and ambulatory care. Jason currently brings his advanced practice students to Baystate Medical Center for clinical rotations.


Theresa Mallick-Searle, MS, RN-BC, ANP-BC

Nurse Practioner; Standford Health Care

Theresa is an Adult Nurse Practitioner with over 27 years’ experience at Stanford Health Care in Palo Alto, California. She received her graduate degree from University of California, San Francisco.

Theresa’s current clinical practice within the Division of Pain Medicine, focuses primarily on evaluation and treatment of individuals suffering from acute and chronic pain conditions in both the hospital and outpatient settings.

As part of her commitment to education and professional development, she lectures extensively on topics surrounding pain management both locally and regionally. She has authored and co-authored numerous articles, abstracts, and book chapters on topics pertaining to pain assessment and management.

Theresa holds board positions in multiple professional organizations. She is on the editorial advisory board of Practical Pain Management and contributes a quarterly article for the Advanced Practice Provider. Theresa is the past co-chair of the pain management special practice group at AANP, as well as the current co-chair of the APRN/PA special interest group at AAPM.

Amongst her numerous honors, the two that stand out as the most treasured were awarded by peer nomination, Nurse Practitioner of the Year (Pain Medicine) – Point of Care Network in 2019, 2021 & 2022, and Advanced Practice Provider of the Year – Stanford Health Care in 2015.


Christina Hanson, FNP-C

Nurse Practitioner; South Denver Gastroenterology

Christina received her Bachelors of Science in Nursing from Bethel University in St. Paul, MN where she graduated cum laude in 2001. In 2005, she returned to school to obtain her MSN after completing the Family Nurse Practitioner program at Regis University. She graduated with honors and was nominated for the Sigma Theta Tau Honor Society.

Christina has been working at South Denver Gastroenterology since 2007 as a nurse practitioner, treating patients with both GI and liver disease and she is a sub investigator in the research department at SDGI. She is a course director and board of trustee for GHAPP and has had the opportunity to participate in educating other healthcare providers across the country as a national speaker. Christina enjoys running and traveling, and she loves spending time with her husband and two beautiful daughters playing in the mountains of Colorado.


Eden M. Miller D.O. A.B.O.M-Diplomat

Dr. Eden Miller, an Osteopathic board-certified Family Practitioner, received her medical degree from Kirksville College of Osteopathic Medicine in 1997. Returning to the Northwest, she completed her residency in Family Practice at East Moreland Hospital in Portland, Oregon. Recently completing her certification in Obesity management, she is the founder of Diabetes Nation a nonprofit organization, and CEO of Diabetes and Obesity Care LLC where she practices with her husband Dr. Kevin Miller in Bend.

Dr. Miller has cultivated a special interest in diabetes, after contracting type-1 diabetes while in medical school. Out of that personal experience, her practice has extended into a subspecialty in diabetes care. An impassioned speaker, Dr. Miller has given over 1250 lectures in the field of Diabetes to health care providers and patients alike, on subjects such as Diabetes Management, CGM Technology, Insulin Pump Therapy, Obesity and Metabolism intervention, Clinical Research, and Healthcare Policy. Her adage for care is that she “only succeeds as a provider if she turns patients into experts on their own disease”.

Dr. Miller believes that a “physiologic patient individualized approach to diabetes intervention is crucial to success. She feels if our nation is to triumph over the ravages of diabetes, a collaborative effort; unhindered by fear of personal scrutiny, and barriers for effective treatment need to be removed”.

For her, Diabetes and Obesity Care provides the foundational model to impact the people that represent this disease and begin the process of restoring hope back to their lives.


Eric Wombwell, PharmD, BCIDP

Clinical Associate Professor; University of Missouri, Kansas City, School of Pharmacy

Dr. Eric Wombwell is a Board Certified Infectious Diseases Pharmacist and Clinical Professor for the Department of Pharmacy Practice and Administration at the University of Missouri - Kansas City, School of Pharmacy. Eric completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center. In his role as a professor at UMKC, Eric covers infectious diseases topics throughout the pharmacy curriculum and anti-infective pharmacology in the dentistry curriculum. Eric maintains a clinical appointment at Centerpoint Medical Center where he provides clinical support for inpatients with infectious diseases, precepts the pharmacy residency infectious diseases rotation, and supports antimicrobial stewardship efforts.

Eric is regularly published in pharmacy and infectious diseases research, and is frequently invited to deliver continuing education presentations locally and nationally to various health-professional audiences. He is recognized for excellence in teaching through various awards, including the “Missouri Pharmacist Association - UMKC Faculty Member of the Year”, and the “University of Missouri- Kansas City Provost’s Award for Excellence in Teaching”.



APEA App

APEA Mobile is a free app for Apple**. Purchases must be made through apea.com and will automatically be synced to your app. Content downloaded to your device from the app can be accessed at any time, even without an internet connection.

Minimum space required: Each video section may take up to 150 MB. Each audio section may take up to 90 MB. Requires iPhone versions 5 and above and iPad Air and Mini and above.


Visit learn.npace.org for additional courses.


**Please note the Android app is currently unavailable.

MP3 PLAYERS

MP3 players are nonrefundable. Defective MP3 players will be replaced up to 6 months from the original shipping date. Replacement MP3 Players will not be shipped until the defective player is received and reviewed by APEA.

PRODUCTS

A refund less shipping cost will be issued for physical products returned to APEA in brand new condition within 30 days from the shipping date. If the product was shrink wrapped, the original shrink wrap must be intact to be eligible for refund. APEA does not pay return shipping charges. APEA reserves the right to change this policy at any time without notice.

All sales are final on the following Clinical Resources (including bundles):

Amelie's Antibiotic Cards

Pediatric Antibiotic Guide

Pharm in a Flash!

Building Blocks Flash Cards

Building Blocks Guide to Growth & Development

Guide to Billing & Coding in the Outpatient Setting

Topical Steroid Prescribing Guide

Tool to Identify Myocardial Infarction

ONLINE AND APP PRODUCTS:

No refunds will be given on products accessed online or in the APEA app.

KITS

Kits associated with webinar events are not returnable. No refunds are provided.

Sort on

There are currently no reviews
Loading...